Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Dose Filgrastim-SD/01 Versus Daily Filgrastim Following ESHAP Chemotherapy for Non-Hodgkin's Lymphoma
NCT00004192Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- May 2000
- Primary completion
- Feb 2001
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegfilgrastim in neutropenia, sponsored by University of Nebraska. Started May 2000; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT00004192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004192.